Sleep and delirium in ICU covid patients a qualitative study
Research type
Research Study
Full title
Patient experiences of sleep and delirum in ICU a retrospective qualitative study
IRAS ID
307336
Contact name
Isla Kempe
Contact email
Sponsor organisation
Lancashire Teaching Hospitals NHS Foundation Trust
Duration of Study in the UK
0 years, 6 months, 27 days
Research summary
It is increasingly recognised that patients with Covid 19 experience neurological/psychiatric side effects, these are wide ranging from stroke to psychosis to intracranial haemorrhage. Additionally, it has long been recognised that patients in ITU often experience issues with sleep disturbance. The reasons for this are multifactorial including a loss of day to night awareness, pain and many bleeping machines. This leads to increased stays in ITU, slower recovery and an increased prevalence of post-traumatic stress disorder upon discharge.
Understanding of sleep disturbances can lead to understanding of ways to reduce the prevalence and signpost to staff issues to look out for. Warning patients of potential after effects of admission may help them process their experience better. We are proposing to interview patients who have been discharged from ITU with covid 19 about their experiences with sleep whilst an inpatient focusing on the effect of any dreams they may have had.
Patients over the age of 18 who have been admitted to RPH ITU with covid 19 would be eligible for participation, patients who could not communicate their experience or who would not have the capacity to consent would not be eligible. Recruitment for the study will take place at the ITU follow up clinic in Royal Preston Hospital, this is currently being run virtually for infection control issues. The study would run over a period of 6 months allowing 3 months for recruitment/interviews and 3 months for data analysis/write-up.REC name
South West - Frenchay Research Ethics Committee
REC reference
22/SW/0046
Date of REC Opinion
21 Mar 2022
REC opinion
Unfavourable Opinion